Orbital Radiotherapy in Grave's Ophthalmopathy 1 Week vs 2 Weeks (OraGO-1 Trial)

NCT06392906 · clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
68
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Janjira Petsuksiri

Collaborators